Head & Neck Trials
B9991016
B9991016 – A randomized double-blind phase 3 study of Avelumab in combination with standard of care chemo-radiotherapy (Cisplatin plus definitive radiation therapy) versus standard of care chemo-radiotherapy in the front-line neck treatment of patients with locally advanced squamous cell carcinoma of the head and neck.
-
What type of cancer? What stage?
- Head and neck cancer.
-
Who is eligible?
- First line treatment.
-
How will I be treated?
- All patients get definitive treatment. Patients may also get Avelumab (immunotherapy).
For physicians: more information about this specific trial at clinicaltrials.gov.
-
At your last checkup, your primary care provider recommended you schedule a breast cancer screening this ...
Continue Reading -
When you own a house, you take care of it with regular maintenance. When you own a car, you take it to ...
Continue Reading -
Let’s start with some good news: colorectal cancer diagnoses and mortality rates are on the decline. ...
Continue Reading -
If you’ve been diagnosed with cancer, you want the care of a team of experts. You’ll find that through ...
Continue Reading